845 articles in this topic
A pilot study finds structured moderate exercise doesn't trigger aortic events in dissection survivors, challenging decades of medical caution.
Key cancer findings: renaming low-risk prostate cancer could save 2,400 lives yearly, tamoxifen cuts breast cancer risk, and rural screening access worsens.
New research links lacunar stroke to enlarged brain blood vessels, not artery plaque — explaining why aspirin often fails these patients.
An 8-hour feeding window extended median lifespan in male mice by 12%, though caloric restriction may explain part of the benefit.
Early data show sustained telomere lengthening in blood cells, while a new licensing deal advances a dystrophin therapy for Duchenne muscular dystrophy.
A renewed five-year partnership will accelerate neurodegenerative disease therapies, including a promising anti-tau antibody already in clinical trials.
BPM31510 improved walking, strength and fatigue in four children with primary CoQ10 deficiency, prompting FDA Phase 3 trial talks.
The Forever Healthy Foundation adds a transparent, AI-assisted peptide evidence library to help cut through hype and find real clinical signal.
A drug developed for ALS shows biological activity in Alzheimer's, suggesting shared mechanisms across neurodegenerative diseases.
New research links H. pylori infection to higher colorectal cancer risk, while gut-brain therapies show real promise for IBS sufferers.
A study of 90,000+ people finds every extra hour of uninterrupted sitting raises cancer mortality risk by 10%, but brief activity can reverse it.
A fractional laser shifted epigenetic markers at 83.9% of aging-linked DNA sites, with visible improvements lasting six months.
